The Traderszone Network

Published in TZ Latest News 3 September, 2015 by The TZ Newswire Staff

Here’s Why Geron Corporation’s Stock Is Ripping Higher Today

Geron Corp.’s stock jumped on the announcement that the New England Journal of Medicine published two papers today highlighting the unprecedented disease-modifying ability of its telomerase inhibitor imetelstat in two blood-based disorders.